Punjab Chemicals & Crop Protection Ltd is a diversified Indian chemical manufacturer that has reinvented itself as a contract development and manufacturing partner - a “go-to CDMO provider” - for the world’s agrochemical and specialty chemical companies. Born in 1975 as a small joint venture making basic chemicals like oxalic acid, it spent five decades adding new chemistries, acquiring capabilities in pharmaceuticals, and entering export markets, before a pivotal strategic shift in 2016 refocused the entire business on contract research and manufacturing services. The recurring approach that explains everything else is a low-cost operator model built on complex, multi-step chemistry, where the company develops efficient processes, secures exclusive long-term contracts with global customers, and often gets those customers to help fund the factory expansion needed to serve them. # Business segments Three manufacturing divisions - agrochemicals, specialty chemicals and pharmaceuticals, and industrial chemicals - all run on a shared contract-manufacturing engine, with an R&D pipeline feeding new molecules into each one. ## 1. Agrochemicals: the company’s largest engine, making crop-protection chemicals for global brands and its own label **The Derabassi plant runs at high utilisation making herbicides, insecticides and fungicides, mostly under exclusive multi-year contracts where the customer often pays for the production line.** - **Contract manufacturing is the core model** - the division makes more than 18 crop-protection products and their intermediate chemicals, serving both direct sales of its own portfolio and dedicated production for multinational agrochemical leaders under long-term agreements. - **Herbicides dominate the mix** - herbicides are the largest product category within the division, and the company has built a strong presence in this segment using chemistries like chlorination, bromination, and cryogenic reactions. - **Running near full tilt** - the Derabassi facility produced 24,575 metric tonnes in the latest year, operating at roughly 81% capacity utilisation, and a debottlenecking exercise was just completed to expand capacity for a fast-growing molecule introduced two years ago. - **New molecules are locked in early** - the company has signed exclusive memoranda of understanding with global customers for high-value agrochemicals and intermediates, with commercial production expected to begin within 12 to 18 months, targeting products with complex processes or those going off-patent. ## 2. Specialty chemicals and pharmaceuticals: the high-value, complex-chemistry division that serves both agro and pharma customers **The Lalru plant makes fine chemicals and active pharmaceutical ingredients using difficult reactions, and it still has vacant land to grow into.** - **A legacy in import substitution** - the division’s roots lie in the 2003 acquisition of Alpha Drugs, a pioneer in making intermediates for semisynthetic penicillins, and it now produces high-quality intermediates, fine chemicals, and APIs for global customers. - **Complex chemistry is the barrier to entry** - the facility handles halogenation, cyanation, butyllithium reactions, and photochlorination, among other chemistries, targeting niche products that involve multi-step synthesis. - **Room to expand into agrochemicals too** - the Lalru site spans 23.5 acres with 6 acres of vacant land available, and the company has already initiated the regulatory process to bifurcate the site so it can manufacture agrochemicals there as well. - **Newer products are accelerating** - products added in the last two to three years are seeing very good growth, and about 40% of all new R&D enquiries now come from outside the agrochemical space, reflecting the division’s broadening scope. ## 3. Industrial chemicals: a niche cash generator with a unique position in food-grade phosphoric acid **The Pune plant is India’s only producer of food-grade phosphoric acid made by the thermal process, supplying the concentrate that goes into the world’s biggest cola brands.** - **India’s sole supplier to beverage giants** - the division is the country’s only manufacturer of food-grade phosphoric acid via the thermal process, certified under FSSC 22000, and supplies leading beverage and pharmaceutical companies across India and abroad. - **High utilisation, with headroom** - the industrial chemical division operated at around 90% capacity utilisation in the latest year, and with existing facility capacity it can add another ₹50-60 crore of revenue beyond its current run-rate of roughly ₹120 crore. - **A new anchor customer is coming** - the division has received in-principle approval from one of the largest beverage manufacturers to supply the entire phosphoric acid requirement for a new facility in Gujarat. - **Also the largest in oxalates** - beyond phosphates and phosphorus pentoxide, the company is the largest producer of oxalic acid and its derivatives, a position it has held since its earliest days. # The CDMO engine: how the company wins and keeps business **Every division feeds off a contract development and manufacturing model where customers sign exclusive long-term deals, often co-invest in the plant, and pass raw-material price changes through to the final bill.** - **Three ways to partner** - the company offers end-to-end support from R&D to commercial scale-up, pure contract manufacturing with technology transfer, or joint capital-expenditure partnerships where the customer funds part of the factory and gets exclusive output under a long-term contract. - **The order book gives visibility** - the company’s long-term contract order book stood at ₹1,500 crores as of FY22, and a large proportion of revenue comes from primary customers who have been with the company for ten years or more. - **No speculative inventory** - the company runs a just-in-time inventory approach, carrying no stock on speculation, and its contracts include an understanding that raw-material price fluctuations are passed through to customers, which protected margins when other chemical companies were hit by high-cost inventory write-downs. - **Targeting ₹50-100 crore per product** - the CDMO strategy deliberately goes after niche, high-value molecules with complex multi-step chemistry, aiming for revenue of ₹50-100 crore per product rather than competing on high-volume commodities. # R&D and product pipeline **A 30-person team across two R&D centres feeds 6-8 new products into the manufacturing engine every year, with a pipeline of more than 25 molecules at pilot stage.** - **New products are already a material slice of revenue** - new products contributed 14% of total revenue in the latest year, growing 16% year-on-year, and the company commercialised four new products in the prior year that brought in 12% of revenue. - **High-value, low-volume molecules** - the pipeline targets products with selling prices ranging from $50 to $300 per kilogram and annual volumes of 40-80 tonnes per product, which means each successful launch can add meaningful revenue without requiring massive new capacity. - **Signed three exclusive MOUs** - the company has signed three exclusive agreements with global customers for high-value agrochemicals and intermediates, with commercialisation expected in 12-18 months and incremental revenue of ₹120-150 crore anticipated over the following two to three years. - **Process improvement is a margin lever** - on most of its main molecules, the R&D team has reduced raw-material cost by 15% to 20% through process redesign, and the company plans to double its R&D spend over the next two years while adding new chemistry skills like pressure reactions and hydrogenation. # Group structure and partners **A single overseas subsidiary in Belgium sells only the parent company’s products, while the promoter group holds just under 40% and the board is majority-independent.** - **One subsidiary, no joint ventures** - the company has one wholly owned subsidiary, SD Agchem (Europe) NV in Belgium, which sells only products supplied by the Indian parent, and it has no material subsidiaries, associates, or joint ventures. - **Global customer base** - named customers include UPL, ADAMA, Corteva, Bayer, Nissan Chemical, Daiichi-Sankyo, Pepsi, Coca-Cola, Lupin, and Laurus Labs, served through four marketing offices around the world. - **Board and leadership** - the board has more than 50% independent directors and the Chairman is an independent director, separated from the Managing Director role; the CEO is a chemical engineer from IIT-B with over 25 years at Reliance Industries and former CEO roles at VVF and Archean Chemicals.